Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17373361 | 0.82 | CA2 (0.39) | TSHRCA2CA1MME | |
| SCHEMBL28433567 | 0.82 | CA2 (0.39) | TSHRCA2CA1MME | |
| SCHEMBL17373358 | 0.82 | CA2 (0.39) | TSHRCA2CA1MME | |
| SCHEMBL29065235 | 0.72 | SMN1; SMN2 (0.38) | CA2CA1 | |
| SCHEMBL17432119 | 0.71 | GAA (0.33) | — | |
| SCHEMBL2553949 | 0.71 | TSHR (0.34) | TSHRCA2CA1 | |
| SCHEMBL18329324 | 0.71 | TSHR (0.34) | TSHRCA2CA1 | |
| Pivalate SCHEMBL10534446 | 0.71 | POLB (0.34) | TSHRCA1 | |
| SCHEMBL9341542 | 0.69 | ALDH1A1 (0.43) | TSHRCA2CA1MME | |
| SCHEMBL9805189 | 0.69 | ALDH1A1 (0.43) | TSHRCA2CA1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170028075-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | Ashvattha Therapeutics, Inc. | 2017-02-02 | — | — | US | claimed |
| US-9526794-B2 | Injectable dendrimer hydrogel nanoparticles | WAYNE STATE UNIVERSITY (US) | 2016-12-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170028075-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | PAM, UACA, FLT1 | TSHR 288/4885CA2 4153/4885CA1 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.